Navigation Links
NIH, DOD grants to fund prostate cancer, diabetes research at UH
Date:6/27/2012

HOUSTON, June 26, 2012 Researchers at the University of Houston (UH) have been awarded more than $862,000 in federal grants to pursue projects related to prostate cancer, diabetes and obesity. The U.S. Department of Defense (DOD) and National Institutes of Health (NIH) will fund two new prostate cancer projects, while a third NIH grant will support diabetes and obesity research in the UH Center for Nuclear Receptors and Cell Signaling (CNRCS). The center's research projects now account for eight active NIH grants, a key indicator in Tier One rankings.

"Success in today's competitive federal funding landscape is validation of the motivation and ingenuity of our researchers," said Dr. Jan-ke Gustafsson, director of CNRCS. "With these new awards we are now able to explore new avenues of investigation into the treatment and prevention of these important diseases."

The DOD awarded a grant of more than $337,000 this month to fund assistant professor Daniel Frigo's project, "CaMKK beta-AMPK Signaling Axis as a Biomarker and Therapeutic Target for Advanced Prostate Cancer." Prostate cancer, the second most common cancer in American men, is a major research focus of the Frigo laboratory. The award will further the team's work with CaMKK beta-AMPK, a signaling pathway that may be an effective target for treating prostate cancer. The project is scheduled to begin by the end of June.

"Grants are critical to our research, not only for funding but also building and maintaining a reputable track record on the national level," said Frigo. "Our team is eager to begin these new projects as we focus on identifying drug targets for possible clinical trials in the next phases of research."

Last month, Frigo additionally was awarded a $150,000 grant from the NIH's National Cancer Institute to expand his established research involving the treatment and prevention of prostate cancer. The project, "Modulation of Branched-Chain Fatty Acids for the Prevention of Prostate Cancer," will examine how the convergence of specific biological cues and our diets may function to promote cancer and could provide guidance for preventing the disease. The project is Frigo's third to be funded by the NIH, since joining the center in 2010.

Gustafsson also was notified recently of another NIH grant that will support expanded uses for the center's state-of-the-art zebrafish laboratory. The National Institute of Environmental Health Sciences awarded his team more than $375,000 to collaborate with UH computer science professor Ioannis Kakadiaris on diabetes and obesity research. The project is expected to be led by Maria Bondesson, a research assistant professor with the center. The project, "Detection of Obesogens and Diabetogens by Zebrafish Screening Models," will entail screening the effects of chemical compounds that may disrupt the development of the endocrine system. It is widely hypothesized that exposure to certain chemical compounds in developed countries may be responsible for the steady increase in obesity and diabetes in the U.S.

In total, the CNRCS has 27 active grants. Overall, the center's active projects account for more than $18 million in research funding at UH, another significant metric for Tier One status. Established in 2009, CNRCS is a focal point of the UH health initiative. The center's investigators are involved in many aspects of nuclear receptor research and focused on understanding the roles of these receptors in health and disease. Cell signaling is part of a complex system of communication where cells signal each other to decide when to generate new cells. Errors in this processing are responsible for the diseases they study.


'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Related medicine news :

1. Washingtons Life Sciences Discovery Fund awards commercialization grants
2. 2 Grand Challenges Explorations grants for global health
3. UC Santa Barbaras Kavli Institute receives 2 grants to explore interface of physics and biology
4. New drug prevents spread of human prostate cancer cells
5. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
6. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
7. Study examines adverse effects among different radiation therapies for prostate cancer
8. Study Casts Doubt on Value of Pricey Prostate Cancer Therapy
9. Warren Buffett Has Early Stage Prostate Cancer
10. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
11. PSA screening to detect prostate cancer can be beneficial to younger and at-risk men
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIH, DOD grants to fund prostate cancer, diabetes research at UH
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: